TransMedics Group, Inc. (TMDX)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about TransMedics Group, Inc. (TMDX)
Company Performance

Current Price

as of Dec 03, 2024

$71.44

P/E Ratio

76.54

Market Cap

$2.4B

Description

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

Metrics

Overview

  • HQAndover, MA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerTMDX
  • Price$71.44-16.09%

Trading Information

  • Market cap$2.40B
  • Float96.65%
  • Average Daily Volume (1m)1,786,702
  • Average Daily Volume (3m)1,709,082
  • EPS$0.99

Company

  • Revenue$401.09M
  • Rev growth (1yr)63.72%
  • Net income$4.22M
  • Gross margin55.85%
  • EBITDA margin8.37%
  • EBITDA$9.10M
  • EV$5.79B
  • EV/Revenue14.44
  • P/E76.54
  • P/S6.36
  • P/B11.42